Drug Development Strategy
Clinical development and lifecycle strategy from early phase through approval.
Biopharma Strategic Advisor & Consulting
Where clinical insight meets product development, medical affairs & commercialization strategy.
Strategic advisory and consulting for biopharma founders and life-sciences leaders — bridging clinical medicine, drug development, medical affairs, and commercialization.
20+ Years in clinical medicine & pharma
Global Drug development & medical affairs leadership
MD Yale · RWJ Medical School · Baylor · MIT
Houston, Texas Global advisor
Who is Ike Ogbaa, MD
Physician, biopharma executive, and trusted advisor.
Dr. Ike pairs frontline clinical experience with biopharma executive leadership across global pharma and emerging biotech — helping teams develop, launch, and commercialize therapies, build medical strategy, and grow with integrity.
From the bedside to the boardroom, he has led drug development and global medical affairs at companies including Immunovant, Bluebird Bio, and Chinook Therapeutics (Novartis), with earlier roles at GSK, Sanofi, Bayer, and Merck.
Read the full story → What I do
Advisory across the biopharma value chain
From medical affairs strategy to launch, leadership, and beyond.
Medical Affairs Strategy
Build and scale the medical affairs function for biotech and emerging pharma.
Drug Launch & Commercialization
Launch readiness and go-to-market strategy across therapeutic areas.
Rare Disease & Specialty
Commercialization strategy for rare and specialty therapeutics.
AI in Pharma Advisory
Apply AI to clinical trials, operations, and regulatory acceleration.
Global Health & Market Access
Emerging-market expansion and equitable access, including sub-Saharan Africa.
Executive & Leadership Coaching
Leadership development for clinical and biopharma leaders.
The approach
Science-led. Patient-focused. Commercially sharp.
Great strategy lives at the intersection of rigorous science and real-world execution. Dr. Ogbaa brings both — translating complex clinical and regulatory realities into clear decisions that move therapies forward.
- Deep medical and scientific credibility
- Launch experience across multiple therapeutic areas
- A genuine commitment to access and health equity
A collaborative approach
From question to lasting impact
01
Discover
Clarify the challenge, stakeholders, and what success looks like.
02
Diagnose
Assess the science, strategy, and gaps with a clinical and commercial lens.
03
Design
Shape a clear, actionable plan tailored to your stage and goals.
04
Deliver
Advisory and execution support to drive momentum.
05
Sustain
Embed the strategy and measure real, lasting impact.
In his words
Perspectives from Dr. Ike
"This is an exciting time in pharma — groundbreaking science is transforming how we tackle serious disease. The work is balancing that innovation with real patient access."
Ike Ogbaa, MD
"AI holds real promise — in trial recruitment, operations, and regulatory speed — but only if we implement it in ways that minimize bias."
Ike Ogbaa, MD
"We have to broaden clinical trial participation in underrepresented regions, including sub-Saharan Africa, so research benefits everyone."
Ike Ogbaa, MD
In the press
Featured stories
Rolling Out · July 2026
How Dr. Ike Went From Immigrant Beginnings to Health Care
A Health IQ feature tracing Dr. Ogbaa's path from immigrating from Nigeria at 14 and relying on welfare assistance to Yale, clinical medicine, and pharmaceutical leadership — why he left the clinic to help develop treatments for diabetes, kidney disease, and sickle cell disease, and his case for a health care system built on prevention rather than treatment.
Read the feature →"He hopes to be remembered as someone who left every person he encountered better off."
Rolling Out, Health IQ
Sheen Magazine · July 2026
From Yale Hardship to Global Healthcare Leadership: How Dr. Ikenna Ogbaa Is Redefining Success Through Service
An exclusive interview on Dr. Ogbaa's journey from working three jobs as a Yale student to serving as Chief Medical Officer — why he left clinical medicine to create global impact, the ideas behind The Triangle of Leadership, and his mission to help one million people from underserved communities reach the highest levels of leadership.
Read the feature →"The highest purpose of success is not to elevate yourself but to elevate someone else."
Ike Ogbaa, MD, in Sheen Magazine
Leadership experience across
ImmunovantBluebird BioChinook, a Novartis companyGSKSanofiBayerMerckLexicon
Ready to bring Dr. Ike into the room?
Whether you're preparing for launch, scaling medical affairs, or planning a keynote — let's start the conversation.